Want to join the conversation?
Specialty biopharmaceutical company $MNK said its BoD has approved a change in the company's fiscal year end to the last Friday in December from the last Friday in September. The company is making this move to better align its financial reporting calendar with its customer base and industry peers.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.